Skip to main content
SpringerLink
Log in

Recent Advances in the Hemodynamic Therapy of Septic Shock

  • Conference paper
Book cover Yearbook of Intensive Care and Emergency Medicine

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 1996))

  • 152 Accesses

Abstract

Septic shock is increasing in incidence and there has apparently been no improvement in mortality since 1958. However, in the last 10 years, there has been a huge advance in understanding of the pathophysiological processes in septic shock. Has this led to anything new that should change our clinical practice at the bedside?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gomez J, Friedman G, Mendonca A, Shahla M, Vincent JL (1995) Mortality in septic shock: Have we made progress? Intensive Care Med 21: S10 (Abst)

    Google Scholar 

  2. Martin C, Papazian L, Perrin GS, Goudin F (1993) Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? Chest 103: 1826–1831

    Article  PubMed  CAS  Google Scholar 

  3. Ziegler EJ, Fisher CJ, Sprung CL, and the HA-1A Sepsis Study Group (1991) Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324: 429–436

    Article  PubMed  CAS  Google Scholar 

  4. McCloskey RV, Straube RC, Sanders C, Smith SM, Smith CR (1994) Treatment of septic shock with monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS trial study group. Ann Int Med 121: 1–5

    PubMed  CAS  Google Scholar 

  5. The National Committee for the Evaluation of Centoxin (1994) The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. Arch Intern Med 154: 2484–2491

    Article  Google Scholar 

  6. Fisher CJ, Marra MN, Palardy JE, Marchbanks CR, Scott RW, Opal SM (1994) Human neutrophil bactericidal/permeability-increasing protein reduces mortality rate from endotoxin challenge: A placebo-controlled study. Crit Care Med 22: 553–558

    Article  PubMed  Google Scholar 

  7. Fisher CJ, Slotman GJ, Opal SM, et al (1994) Initial evaluation of the interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized open-label, placebo-controlled multicenter trial. Crit Care Med 22: 12–21

    PubMed  Google Scholar 

  8. Abraham E, Wunderink R, Silverman H, for the TNF-alpha Mab Sepsis Study Group (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. JAMA 273: 934–941

    Article  PubMed  CAS  Google Scholar 

  9. Fisher CJ, Dhainaut JF, Opal SM, for the Phase III rhIL-lra Sepsis Syndrome Study Group (1994) Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial. JAMA 271: 1836–1843

    Article  PubMed  Google Scholar 

  10. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012

    Article  PubMed  CAS  Google Scholar 

  11. Wolfe TA, Dasta JF (1995) Use of nitric oxide synthetase inhibitors as a novel treatment for septic shock. Ann Pharmacother 29: 36–46

    PubMed  CAS  Google Scholar 

  12. Statman R, Cheng W, Cunningham IN, et al (1994) Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 57: 93–98

    Article  PubMed  CAS  Google Scholar 

  13. Pastor C, Teisseire B, Vicaut E, Payen D (1994) Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 22: 465–469

    Article  PubMed  CAS  Google Scholar 

  14. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129: 149–155

    Article  PubMed  CAS  Google Scholar 

  15. Petros A, Bennett ED, Vallance P (1991) Effects of nitric oxide synthesis inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558

    Article  PubMed  CAS  Google Scholar 

  16. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthesis inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39

    Article  PubMed  CAS  Google Scholar 

  17. Pastor CM, Payen DM (1994) Effect of modifying nitric oxide pathway on liver circulation in a rabbit endotoxic shock model. Shock 2: 196–202

    Article  PubMed  CAS  Google Scholar 

  18. Spain DA, Wilson MA, Garrision RN (1994) Nitric oxide synthesis inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 116: 322–331

    PubMed  CAS  Google Scholar 

  19. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM (1994) Inhibition of nitric oxide (NO) synthesis is detrimental during endotoxemia. Arch Surg 129: 142–148

    Article  PubMed  CAS  Google Scholar 

  20. Kilbourn RG, Cromeens DM, Chelly FD, Griffith OW (1994) NG-methly-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxic dogs. Crit Care Med 22: 1835–1840

    PubMed  CAS  Google Scholar 

  21. Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D (1994) Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106: 250–256

    Article  PubMed  CAS  Google Scholar 

  22. Herity N, Allen JD, Silke B, Adgey AA (1994) Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis. Br J Pharmacol 112: 423–428

    PubMed  CAS  Google Scholar 

  23. Keaney JF, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J (1994) Methylene blue reverses endotoxin-induced hypotension. Circ Res 74: 1120–1125

    Google Scholar 

  24. Preiser JC, Lejeune P, Roman A, et al (1995) Methylene blue administration in septic shock: A clinical trial. Crit Care Med 23: 259–264

    Article  PubMed  CAS  Google Scholar 

  25. Weitzberg E, Lundberg JM, Rudehill A (1995) Inhibitory effects of diclofenac on the endotoxin shock response in relation to endothelin turnover in the pig. Acta Anaesth Scand 39: 50–59

    Article  PubMed  CAS  Google Scholar 

  26. Astiz ME, Rackow EC, Falk JL, Kaufman BS, Weil MH (1987) Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 15: 26–28

    Article  PubMed  CAS  Google Scholar 

  27. Boyd O, Bennett ED (1992) Is oxygen consumption an important clinical target? In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine 1992, SpringerVerlag, Berlin, pp 310–322

    Google Scholar 

  28. Boyd O, Grounds RM, Bennett ED (1994) Peri-operative mortality is reduced by cardiovascular optimization: Evidence, physiology and mechanisms. In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine 1994, Springer-Verlag, Berlin, pp 325–336

    Google Scholar 

  29. Tuchschmidt J, Fried J, Astiz M, Rackow E (1992) Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 102: 216–220

    Article  PubMed  CAS  Google Scholar 

  30. Vallet B, Chopin C, Curtis SE, et al (1993) Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective multicenter study. Crit Care Med 21: 1868–1875

    Article  PubMed  CAS  Google Scholar 

  31. Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D (1994) Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330: 1717–1722

    Article  PubMed  CAS  Google Scholar 

  32. Gattinoni L, Brazzi L, Pelosi P, et al (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333: 1025–1032

    Article  PubMed  CAS  Google Scholar 

  33. Smithies M, Yee TH, Jackson L, Beale R, Bihari D (1994) Protecting the gut and liver in the critically ill: Effects of dopexamine. Crit Care Med 22: 789–795

    Article  PubMed  CAS  Google Scholar 

  34. Gutierrez G, Clarke C, Brown SD, Price K, Ortiz L, Nelson C (1994) Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 150: 324–329

    PubMed  CAS  Google Scholar 

  35. Bersten AD, Rutten AJ (1995) Renovascular interaction of epinephrine, dopamine and intraperitoneal sepsis. Crit Care Med 23: 537–544

    Article  PubMed  CAS  Google Scholar 

  36. Yang S, Hauptman JG (1994) The efficacy of heparin and antithrombin III in fluidresuscitated cecal ligation and puncture. Shock 2: 433–437

    Article  PubMed  CAS  Google Scholar 

  37. Harper PL, Williamson L, Park G, Smith JK, Carrell RW (1991) A pilot study of antithrombin replacement in intensive care management: The effects on mortality, coagulation and renal function. Trans Med 1: 121–128

    Article  CAS  Google Scholar 

  38. Scharfman WB, Tillotoson JR, Taf EG (1979) Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl Med 300: 1277–1278

    CAS  Google Scholar 

  39. Beca J, Butt W (1994) Extracorporeal membrane oxygenation for refractory septic shock in children. Pediatrics 93: 726–729

    PubMed  CAS  Google Scholar 

  40. Aoki H, Kodama M, Tani T, Hanasawa K (1994) Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilizer fiber. Am J Surg 167: 412–417

    Article  PubMed  CAS  Google Scholar 

  41. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324: 1852–1857

    Article  PubMed  CAS  Google Scholar 

  42. Bakker J, Zhang H, Depierreux M, van Asbeck S, Vincent JL (1994) Effects of N-acetylcysteine in endotoxic dogs. J Crit Care 9: 236–243

    Article  PubMed  CAS  Google Scholar 

  43. Suter PM, Domenighetti G, Schallert MD, Laverriere MC, Ritz R, Petter C (1994) Nacetylcysteine enhances recovery from acute lung injury in man. Chest 105: 190–194

    Article  PubMed  CAS  Google Scholar 

  44. Spies CD, Reinhart K, Witt I, et al (1994) Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study. Crit Care Med 22: 1738–1746

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. O. Boyd
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Clinical Director) (Clinical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Boyd, O. (1996). Recent Advances in the Hemodynamic Therapy of Septic Shock. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 1996. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80053-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-80053-5_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60552-2

  • Online ISBN: 978-3-642-80053-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation